Rating History for Stemline Therapeutics (STML) by Roth/MKM
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/24/2019 | Jerry Issacson | New Coverage | Buy (N/A) |
33.00 (N/A) |
15.13 (11.83) |
-21.81% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/24/2019 | Jerry Issacson | New Coverage | Buy (N/A) |
33.00 (N/A) |
15.13 (11.83) |
-21.81% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
